| Bioactivity | Blontuvetmab (AT 004)is a caninized CD20 monoclonal antibody. Blontuvetmab can be used for the research of Canine B-cell lymphoma[1]. |
| Name | Blontuvetmab |
| CAS | 1608112-78-2 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Mizuno T, et, al. Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment. Sci Rep. 2020 Jul 10;10(1):11476. |